Polymorphisms of tumor-related genes IL-10, PSCA, MTRR and NOC3L are associated with the risk of gastric cancer in the Chinese Han population

Cancer Epidemiology

Volumn 36, Issue 6, 2012, Pages

  Yuan, Li Juan ^a   Jin, Tian Bo ^b   Yin, Ji Kai ^a   Du, Xi Lin ^a   Wang, Qing ^a   Dong, Rui ^a   Wang, Sheng Zhi ^a   Cui, Yan ^b   Chen, Chao ^b   Lu, Jian Guo ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

Author keywords

Case control study; Gastric cancer; IL 10; MTRR; NOC3L; PSCA; Single nucleotide polymorphism (SNP)

Indexed keywords

INTERLEUKIN 10; MEMBRANE PROTEIN; METHIONINE SYNTHASE REDUCTASE; NUCLEOLAR COMPLEX ASSOCIATED 3 HOMOLOG PROTEIN; PROSTATE STEM CELL ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE CONTROL; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ASIAN CONTINENTAL ANCESTRY GROUP; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FERREDOXIN-NADP REDUCTASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GPI-LINKED PROTEINS; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84868303825     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.05.016     Document Type: Article

References (48)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Yuan T., Deng S., Chen M., Chen W., Lu W., Huang H., et al. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population. Cancer Epidemiol 2011, 35(2):170-174.
3. Wang J.Y., Yang I.P., Wu D.C., Huang S.W., Wu J.Y., Juo S.H. Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwanese patients with gastric cancer. Clin Chim Acta 2010, 411(19-20):1432-1436.
4. Aung P.P., Matsumura S., Kuraoka K., Kunimitsu K., Yoshida K., Matsusaki K., et al. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 2005, 14(5):1151-1154.
5. Yamada H., Shinmura K., Ikeda S., Tao H., Otani T., Hanaoka T., et al. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand J Gastroenterol 2007, 42(12):1479-1485.
6. Sakamoto H., Yoshimura K., Saeki N., Katai H., Shimoda T., Matsuno Y., et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008, 40(6):730-740.
7. Wang S., Tian L., Zeng Z., Zhang M., Wu K., Chen M., et al. IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese. BMC Gastroenterol 2010, 10:15.
8. Wang S., Zhang M., Zeng Z., Tian L., Wu K., Chu J., et al. IkappaBalpha polymorphisms were associated with increased risk of gastric cancer in a southern Chinese population: a case-control study. Life Sci 2011, 88(17-18):792-797.
9. Sugimoto M., Furuta T., Shirai N., Nakamura A., Kajimura M., Sugimura H., et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 2007, 22(9):1443-1449.
10. Sugimoto M., Yamaoka Y., Furuta T. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol 2010, 16(10):1188-1200.
11. Angeletti S., Galluzzo S., Santini D., Ruzzo A., Vincenzi B., Ferraro E., et al. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol 2009, 70(9):729-732.
12. Guo W., Dong Z., Guo Y., Chen Z., Yang Z., Kuang G., et al. Polymorphisms of transforming growth factor-beta1 associated with increased risk of gastric cardia adenocarcinoma in north China. Int J Immunogenet 2011, 38(3):215-224.
13. Perri F., Piepoli A., Bonvicini C., Gentile A., Quitadamo M., Di Candia M., et al. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine 2005, 30(5):293-302.
14. Gabriel S., Ziaugra L., Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2009, 12. Unit 2 [Chapter 2].
15. Pardini B., Kumar R., Naccarati A., Prasad R.B., Forsti A., Polakova V., et al. MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic. Mutat Res 2011, 721(1):74-80.
16. Jokic M., Brcic-Kostic K., Stefulj J., Ivkovic T.C., Bozo L., Gamulin M., et al. Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer. DNA Cell Biol 2011, 30(10):771-776.
17. Collin S.M., Metcalfe C., Refsum H., Lewis S.J., Smith G.D., Cox A., et al. Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Cancer Epidemiol Biomarkers Prev 2010, 19(11):2833-2838.
18. Gast A., Bermejo J.L., Flohr T., Stanulla M., Burwinkel B., Schrappe M., et al. Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia 2007, 21(2):320-325.
19. Zhang Z., Shi Q., Liu Z., Sturgis E.M., Spitz M.R., Wei Q. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev 2005, 14(5):1188-1193.
20. Kwak S.Y., Kim U.K., Cho H.J., Lee H.K., Kim H.J., Kim N.K., et al. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res 2008, 28(5A):2807-2811.
21. Wettergren Y., Odin E., Carlsson G., Gustavsson B. MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer. Mol Med 2010, 16(9-10):425-432.
22. Stolzenberg-Solomon R.Z., Qiao Y.L., Abnet C.C., Ratnasinghe D.L., Dawsey S.M., Dong Z.W., et al. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003, 12(11 Pt. 1):1222-1226.
23. Mostowska A., Myka M., Lianeri M., Roszak A., Jagodzinski P.P. Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin Biochem 2011, 44(8-9):596-600.
24. Burcos T., Toma M., Stavarachi M., Cimponeriu D., Apostol P., Popa E., et al. MTRR polymorphism and the risk for colorectal and breast cancer in Romanian patients - a preliminary study. Chirurgia (Bucur) 2010, 105(3):379-382.
25. Johmura Y., Osada S., Nishizuka M., Imagawa M. FAD24, a regulator of adipogenesis, is required for the regulation of DNA replication in cell proliferation. Biol Pharm Bull 2008, 31(6):1092-1095.
26. Tominaga K., Johmura Y., Nishizuka M., Imagawa M. Fad24, a mammalian homolog of Noc3p, is a positive regulator in adipocyte differentiation. J Cell Sci 2004, 117(Pt. 25):6217-6226.
27. Johmura Y., Osada S., Nishizuka M., Imagawa M. FAD24 acts in concert with histone acetyltransferase HBO1 to promote adipogenesis by controlling DNA replication. J Biol Chem 2008, 283(4):2265-2274.
28. Mendes-Pereira A.M., Sims D., Dexter T., Fenwick K., Assiotis I., Kozarewa I., et al. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen. Proc Natl Acad Sci U S A 2011.
29. Johmura Y., Suzuki M., Osada S., Nishizuka M., Imagawa M. FAD24, a regulator of adipogenesis and DNA replication, inhibits H-RAS-mediated transformation by repressing NF-kappaB activity. Biochem Biophys Res Commun 2008, 369(2):464-470.
30. Liu J., Song B., Wang J.L., Li Z.J., Li W.H., Wang Z.H. Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol 2011, 17(10):1362-1367.
31. Zeng X., Li Y., Liu T., Zhang J., Diverse H. Pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China. Mol Cell Biochem 2011.
32. Sun F., Sun Y., Yu Z., Zhang D., Zhang J., Song B., et al. Interleukin-10 gene polymorphisms influence susceptibility to cachexia in patients with low-third gastric cancer in a Chinese population. Mol Diagn Ther 2010, 14(2):95-100.
33. Zhuang W., Wu X.T., Zhou Y., Liu L., Liu G.J., Wu T.X., et al. Interleukin10-592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci 2010, 55(6):1525-1532.
34. Zhou Y., Hu W., Zhuang W., Wu X. Interleukin-10-1082 promoter polymorphism and gastric cancer risk in a Chinese Han population. Mol Cell Biochem 2011, 347(1-2):89-93.
35. Won H.H., Kim J.W., Kim M.J., Kim S., Park J.H., Lee K.A. Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians. Cytokine 2010, 51(1):73-77.
36. Ko K.P., Park S.K., Cho L.Y., Gwack J., Yang J.J., Shin A., et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr 2009, 139(5):1008-1012.
37. Saeki N., Sakamoto H., Yoshida T. Genome-wide association study of gastric cancer and GeMDBJ database. Nihon Rinsho 2009, 67(6):1227-1232.
38. Lu Y., Chen J., Ding Y., Jin G., Wu J., Huang H., et al. Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population. Int J Cancer 2010, 127(9):2183-2189.
39. Ou J., Li K., Ren H., Bai H., Zeng D., Zhang C. Association and haplotype analysis of prostate stem cell antigen with gastric cancer in Tibetans. DNA Cell Biol 2010, 29(6):319-323.
40. Sala N., Munoz X., Travier N., Agudo A., Duell E.J., Moreno V., et al. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study. Int J Cancer 2011.
41. Wu C., Wang G., Yang M., Huang L., Yu D., Tan W., et al. Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population. Mol Carcinog 2009, 48(12):1131-1138.
42. Song H.R., Kim H.N., Piao J.M., Kweon S.S., Choi J.S., Bae W.K., et al. Association of a common genetic variant in prostate stem-cell antigen with gastric cancer susceptibility in a Korean population. Mol Carcinog 2011, 50(11):871-875.
43. Zeng Z., Wu X., Chen F., Yu J., Xue L., Hao Y., et al. Polymorphisms in prostate stem cell antigen gene rs2294008 increase gastric cancer risk in Chinese. Mol Carcinog 2011, 50(5):353-358.
44. Wang M., Bai J., Tan Y., Wang S., Tian Y., Gong W., et al. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer 2011, 129(5):1207-1213.
45. Sala N., Munoz X., Travier N., Agudo A., Duell E.J., Moreno V., et al. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study. Int J Cancer 2012, 130(10):2417-2427.
46. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69(1):138-147.
47. Li S., Jin T., Zhang J., Lou H., Yang B., Li Y., et al. Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiol 2012.
48. Xue H., Lin B., An J., Zhu Y., Huang G. Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer 2012, 12(1):102.